These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 34550615)

  • 1. Muscle biopsy and MRI findings in ANO5-related myopathy.
    Holm-Yildiz S; Witting N; de Stricker Borch J; Kass K; Khawajazada T; Krag T; Vissing J
    Muscle Nerve; 2021 Dec; 64(6):743-748. PubMed ID: 34550615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anoctamin 5 (ANO5) Muscle Disorders: A Narrative Review.
    Soontrapa P; Liewluck T
    Genes (Basel); 2022 Sep; 13(10):. PubMed ID: 36292621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and molecular findings in a cohort of ANO5-related myopathy.
    Silva AMS; Coimbra-Neto AR; Souza PVS; Winckler PB; Gonçalves MVM; Cavalcanti EBU; Carvalho AADS; Sobreira CFDR; Camelo CG; Mendonça RDH; Estephan EDP; Reed UC; Machado-Costa MC; Dourado-Junior MET; Pereira VC; Cruzeiro MM; Helito PVP; Aivazoglou LU; Camargo LVD; Gomes HH; Camargo AJSD; Pinto WBVDR; Badia BML; Libardi LH; Yanagiura MT; Oliveira ASB; Nucci A; Saute JAM; França-Junior MC; Zanoteli E
    Ann Clin Transl Neurol; 2019 Jul; 6(7):1225-1238. PubMed ID: 31353849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistent asymptomatic or mild symptomatic hyperCKemia due to mutations in ANO5: the mildest end of the anoctaminopathies spectrum.
    Panadés-de Oliveira L; Bermejo-Guerrero L; de Fuenmayor-Fernández de la Hoz CP; Cantero Montenegro D; Hernández Lain A; Martí P; Muelas N; Vilchez JJ; Domínguez-González C
    J Neurol; 2020 Sep; 267(9):2546-2555. PubMed ID: 32367299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Muscle involvement assessed by quantitative magnetic resonance imaging in patients with anoctamin 5 deficiency.
    Khawajazada T; Kass K; Rudolf K; de Stricker Borch J; Sheikh AM; Witting N; Vissing J
    Eur J Neurol; 2021 Sep; 28(9):3121-3132. PubMed ID: 34145687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anoctamin 5 Knockout Mouse Model Recapitulates LGMD2L Muscle Pathology and Offers Insight Into in vivo Functional Deficits.
    Thiruvengadam G; Sreetama SC; Charton K; Hogarth M; Novak JS; Suel-Petat L; Chandra G; Allard B; Richard I; Jaiswal JK
    J Neuromuscul Dis; 2021; 8(s2):S243-S255. PubMed ID: 34633328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anoctamin 5 (ANO5) muscular dystrophy-three different phenotypes and a new histological pattern.
    Seguí F; Gonzalez-Quereda L; Sanchez A; Matas-García A; Garrabou G; Rodriguez MJ; Gallano P; Grau JM; Milisenda JC
    Neurol Sci; 2020 Oct; 41(10):2967-2971. PubMed ID: 32399949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histopathological correlations and fat replacement imaging patterns in recessive limb-girdle muscular dystrophy type 12.
    De Wel B; Huysmans L; Depuydt CE; Goosens V; Peeters R; Santos FP; Thal DR; Dupont P; Maes F; Claeys KG
    J Cachexia Sarcopenia Muscle; 2023 Jun; 14(3):1468-1481. PubMed ID: 37078404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anoctamin-5 Muscular Dystrophy: Report of Two Cases with Different Phenotypes and Genotypes from the Indian Subcontinent.
    Mahajan S; Dhall A; Jassal B; Saluja A; Faruq M; Suri V; Rajan R; Vishnu VY; Sharma MC
    Neurol India; 2022; 70(5):2169-2173. PubMed ID: 36352632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First familial limb-girdle muscular dystrophy 2L in China: Clinical, imaging, pathological, and genetic features.
    Hu B; Xiong L; Zhou Y; Lu X; Xiong Q; Liu Q; Qi X; Ding W
    Medicine (Baltimore); 2018 Sep; 97(38):e12506. PubMed ID: 30235762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic anoctamin-5 protein defect in patients with ANO5-mutated muscular dystrophy.
    Vihola A; Luque H; Savarese M; Penttilä S; Lindfors M; Leturcq F; Eymard B; Tasca G; Brais B; Conte T; Charton K; Richard I; Udd B
    Neuropathol Appl Neurobiol; 2018 Aug; 44(5):441-448. PubMed ID: 28489263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective pattern of muscle involvement seen in distal muscular dystrophy associated with anoctamin 5 mutations: a follow-up muscle MRI study.
    Mahjneh I; Bashir R; Kiuru-Enari S; Linssen W; Lamminen A; Visser Md
    Neuromuscul Disord; 2012 Oct; 22 Suppl 2():S130-6. PubMed ID: 22980764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anoctamin-5 related muscle disease: clinical and genetic findings in a large European cohort.
    de Bruyn A; Montagnese F; Holm-Yildiz S; Scharff Poulsen N; Stojkovic T; Behin A; Palmio J; Jokela M; De Bleecker JL; de Visser M; van der Kooi AJ; Ten Dam L; Domínguez González C; Maggi L; Gallone A; Kostera-Pruszczyk A; Macias A; Łusakowska A; Nedkova V; Olive M; Álvarez-Velasco R; Wanschitz J; Paradas C; Mavillard F; Querin G; Fernández-Eulate G; Quinlivan R; Walter MC; Depuydt CE; Udd B; Vissing J; Schoser B; Claeys KG
    Brain; 2023 Sep; 146(9):3800-3815. PubMed ID: 36913258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of muscular dystrophy in a CRISPR-engineered mutant rabbit model with frame-disrupting ANO5 mutations.
    Sui T; Xu L; Lau YS; Liu D; Liu T; Gao Y; Lai L; Han R; Li Z
    Cell Death Dis; 2018 May; 9(6):609. PubMed ID: 29789544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intramuscular interstitial amyloid deposition does not impact anoctaminopathy-5 phenotype.
    Anandan C; Milone M; Liewluck T
    Muscle Nerve; 2019 Jan; 59(1):133-137. PubMed ID: 30320887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenotypic Spectrum of Myopathies with Recessive Anoctamin-5 Mutations.
    Vázquez J; Lefeuvre C; Escobar RE; Luna Angulo AB; Miranda Duarte A; Delia Hernandez A; Brisset M; Carlier RY; Leturcq F; Durand-Canard MC; Nicolas G; Laforet P; Malfatti E
    J Neuromuscul Dis; 2020; 7(4):443-451. PubMed ID: 32925086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel ANO5 splicing variant in a LGMD2L patient leads to production of a truncated aggregation-prone Ano5 peptide.
    Xu J; Xu L; Lau YS; Gao Y; Moore SA; Han R
    J Pathol Clin Res; 2018 Apr; 4(2):135-145. PubMed ID: 29665321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperckemia and myalgia are common presentations of anoctamin-5-related myopathy in French patients.
    Papadopoulos C; LaforÊt P; Nectoux J; Stojkovic T; Wahbi K; Carlier RY; Carlier PG; Leonard-Louis S; Leturcq F; Romero N; Eymard B; Behin A
    Muscle Nerve; 2017 Dec; 56(6):1096-1100. PubMed ID: 28187523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel ANO5 homozygous microdeletion causing myalgia and unprovoked rhabdomyolysis in an Arabic man.
    Lahoria R; Winder TL; Lui J; Al-Owain MA; Milone M
    Muscle Nerve; 2014 Oct; 50(4):610-3. PubMed ID: 24889862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anoctamin 5 muscular dystrophy in Denmark: prevalence, genotypes, phenotypes, cardiac findings, and muscle protein expression.
    Witting N; Duno M; Petri H; Krag T; Bundgaard H; Kober L; Vissing J
    J Neurol; 2013 Aug; 260(8):2084-93. PubMed ID: 23670307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.